IP Verse

Method For Establishing, Restoring, And Preserving Homeostasis Of The Ocular Surface - EP3525799

The patent EP3525799 was granted to Icom Medical on Jan 26, 2022. The application was originally filed on Oct 2, 2017 under application number EP17817868A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3525799

ICOM MEDICAL
Application Number
EP17817868A
Filing Date
Oct 2, 2017
Status
Granted And Under Opposition
Dec 24, 2021
Grant Date
Jan 26, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BAUSCH LOMB IRELANDOct 26, 2022MAIWALDADMISSIBLE

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS5033252
DESCRIPTIONUS5052558
DESCRIPTIONUS5323907
INTERNATIONAL-SEARCH-REPORTWO2008126803
OPPOSITIONDE10360425
OPPOSITIONWO2017012712
OPPOSITIONWO2018069763

Non-Patent Literature (NPL) Citations (10) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Anonymous, "HYLO COMOD® Gebrauchsanweisung / Instructions for use", URSAPHARM, (20210301), URSAPHARM , URL: https://hylo.at/eye-care/user_upload_AT/downloads/hylo_comod/Beipackzettel_Hylo_Comod.pdf, (20240306), XP093138488-
OPPOSITION- Anonymous, "HYLO FRESH® Gebrauchsanweisung / Instructions for use", URSAPHARM, (20210301), URSAPHARM, (20240306), XP093138484-
OPPOSITION- Anonymous, "HYLO GEL® Gebrauchsanweisung / Instructions for use", URSAPHARM, (20210301), URSAPHARM, URL: https://hylo.at/eye-care/user_upload_AT/downloads/hylo_gel/Beipackzettel_Hylo_Gel.pdf, (20240306), XP093138492-
OPPOSITION- Anonymous, "ICD-10 Coding for dry eye", Tear Lab. Corp., (20150101), Tear Lab. Corp., URL: https://www.tearlab.com/pdfs/940089_Rev_A_-_ICD-10_Coding_for_Dry_Eye_-_FINAL_-_9-23-15.pdf, (20221109), XP055979553-
OPPOSITION- CONDON P I, ET AL., "Double blind, randomised, placebo controlled, crossover, multicentre study to determine the efficacy of a 0.1% (w/v) sodium hyaluronate solution (Fermavisc) in the treatment of dry eye syndrome", British Journal of Ophthalmology, GB , (19991001), vol. 83, no. 10, ISSN 0007-1161, pages 1121 - 1124, XP001008246-
OPPOSITION- Galifa, "Neu gegen trockene Augen: Comfort Shield®", Optikum, (20151111), URL: https://www.optikum.at/Neu-gegen-trockene-Augen-Comfort-Shield/, (20210115), XP055765602-
OPPOSITION- Polack Frank M., Mcniece, M. T., "The Treatment of Dry Eyes with Na Hyaluronate (Healon®) - A Preliminary Report", Cornea, (19820601), vol. 1, no. 2, pages 133 - 136, XP055979538-
OPPOSITION- Radda T. M., N, Stelzer, I. Gottlob, "Trockenes Auge - Therapie mit hypoosmolaren Natrium-Hyaluronat-Tropfen", Spektrum Augenheilkd, (19890101), vol. 3/4, pages 174 - 176, XP055979551-
OPPOSITION- Dorothea Groß, Marc Childs, Jean-Marie Piaton, "Comparison of 0.2% and 0.18% hyaluronate eye drops in patients with moderate to severe dry eye with keratitis or keratoconjunctivitis", Clinical Ophthalmology, (20170401), vol. 11, doi:10.2147/OPTH.S131384, pages 631 - 638, XP055603466
OPPOSITION- Müller-Lierheim Wolfgang G.K., "Why Chain Length of Hyaluronan in Eye Drops Matters", Diagnostics, MDPI, CH, CH , (20200801), vol. 10, no. 8, doi:10.3390/diagnostics10080511, ISSN 2075-4418, page 511, XP055979540

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents